| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.095 | 0.08 |